Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 29 January 2026

Compass Group share price slips: what traders watch before the Feb. 5 update

Compass Group share price slips: what traders watch before the Feb. 5 update

Compass Group shares slipped 0.2% to 2,194 pence in early London trading Thursday, after closing at 2,198. Around 109,000 shares changed hands as investors awaited a company update at the annual general meeting set for 10:30 a.m. The stock’s 52-week range stands between 2,167 and 2,853 pence. The FTSE 100 fell 0.5% Wednesday amid shifting rate expectations and a U.S. tech rally.
29 January 2026
·
GSK shares tick higher after Citi’s neutral call as Feb. 4 results loom

GSK shares tick higher after Citi’s neutral call as Feb. 4 results loom

GSK shares rose 0.34% to 1,823.75 pence early Thursday in London after a 2.42% drop Wednesday. Citi began coverage with a Neutral rating and a 1,900p target, noting pipeline improvements but warning on valuation. Investors await GSK’s Feb. 4 earnings for updates on vaccines, HIV treatments, and 2026 guidance. GSK’s RSV vaccine Arexvy recently gained EU approval for adults 18 and older.
29 January 2026
··
Anglo American share price jumps as copper hits record highs; what investors watch next

Anglo American share price jumps as copper hits record highs; what investors watch next

Anglo American shares rose 4.1% to 3,618 pence in early London trading Thursday after copper prices hit a record high, with the LME benchmark contract jumping 6.3% to $13,913.50 a ton. Glencore reported an 11% drop in 2025 copper output, citing lower grades and water shortages at the Collahuasi mine. Anglo American will release its Q4 production report on Feb. 5.
29 January 2026
···
LSEG share price nudges higher after buyback notice as London trading kicks off

LSEG share price nudges higher after buyback notice as London trading kicks off

London Stock Exchange Group shares rose 0.1% to 8,304 pence in early trading Thursday after announcing the purchase and planned cancellation of 209,783 shares on Jan. 28. The buyback follows a program launched in November. Investors are awaiting LSEG’s preliminary results due Feb. 26. The FTSE 100 slipped 0.5% Wednesday amid cautious sentiment after the U.S. Federal Reserve held rates steady.
29 January 2026
·
Imperial Brands share price slips as buyback rolls on; AGM clears dividend

Imperial Brands share price slips as buyback rolls on; AGM clears dividend

Imperial Brands shares slipped 0.3% to 3,019p in early London trading Thursday after announcing further share buybacks for cancellation. The company repurchased 289,199 shares Wednesday and 195,136 shares Tuesday, both via Morgan Stanley. Shareholders approved all AGM resolutions, including the final dividend. The stock goes ex-dividend Feb. 19, with payment due March 31.
29 January 2026
···
Rolls-Royce share price in focus: Delta Airbus order and buyback filing tee up London open

Rolls-Royce share price in focus: Delta Airbus order and buyback filing tee up London open

Rolls-Royce shares fell 2.6% Wednesday to £12.08, underperforming the FTSE 100. Delta Air Lines ordered 31 Airbus widebodies powered by Rolls-Royce Trent engines, with deliveries from 2029. Rolls-Royce repurchased 845,685 shares on Jan. 28 as part of its £200 million buyback. CEO Tufan Erginbilgic and CFO Helen McCabe sold shares to cover tax after incentive plan vesting.
29 January 2026
···
ABB Q4 earnings spark $2 billion buyback as orders surge; 2026 outlook targets up to 9% growth

ABB Q4 earnings spark $2 billion buyback as orders surge; 2026 outlook targets up to 9% growth

ABB launched a $2 billion share buyback and proposed raising its dividend after Q4 orders jumped 36% to $10.3 billion. Revenue rose 13% to $9.05 billion, with operational EBITA up 19% to $1.59 billion, beating analyst forecasts. The company expects 7%-10% comparable revenue growth in Q1 and 6%-9% for 2026. ABB’s robotics division was excluded from results as it is being sold.
29 January 2026
··
Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

Seatrium shares slipped 0.5% to S$2.11 in Thursday afternoon trading, ahead of its Feb. 26 full-year results. The company remains locked in arbitration with Aibel over the DolWin 5 project, with claims totaling nearly 300 million euros. Both parties say any valid claims should be covered by existing consortium funds. The arbitration’s financial impact remains uncertain.
29 January 2026
·
CapitaLand Investment stock price nears S$3.10 after directors’ treasury-share transfer

CapitaLand Investment stock price nears S$3.10 after directors’ treasury-share transfer

CapitaLand Investment shares rose 1.0% to S$3.09 on Thursday, with 7.4 million shares traded after the company awarded 317,809 shares to non-executive directors, valued at S$957,157. Singapore’s central bank kept policy steady but signaled rising inflation risks. CapitaLand Ascott Trust reports results after the close, ahead of CapitaLand Investment’s full-year results on Feb. 11.
29 January 2026
·
Keppel share price slips as Aster SAF plant study lands; next catalyst is Feb 5 results

Keppel share price slips as Aster SAF plant study lands; next catalyst is Feb 5 results

Keppel shares fell 0.27% to S$11.02 in afternoon trading after announcing a study with Aster for an ethanol-to-jet sustainable aviation fuel facility on Jurong Island. The project targets up to 100,000 tonnes annual output but awaits regulatory approval and a final investment decision. Investors are watching for capex details and the February 5 earnings report. Keppel said the plan won’t affect earnings this year.
29 January 2026
··
1 … 138 139 140 141 142 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
New York, Feb 7, 2026, 11:29 ET — Market closed. AbbVie shares closed up 2% on Friday at $223.43, extending a second straight session of gains as U.S. stocks rallied. The stock is still roughly 9% below its 52-week high, and trading volume ran a bit under its recent average. (MarketWatch) The bounce comes as investors work through AbbVie’s post-earnings reset and what it means for 2026. The drugmaker said fourth-quarter net revenues rose 10% to $16.618 billion and adjusted profit per share—excluding certain items—was $2.71; it forecast 2026 adjusted earnings of $14.37 to $14.57 a share. Chief Executive Robert
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop